Genetika+

📍 Tel Aviv, Israel🗓 Founded 2017👥 31 employees💰 Last funded Sep 2018
Biotechnology Research🌐 genetikaplus.com
Website LinkedIn
Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
2
Frequently asked questions
Who invested in Genetika+?
Genetika+ has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Genetika+ last raise funding?
The most recent investment in Genetika+ recorded on gritt.io was in September 2018.
When was Genetika+ founded?
Genetika+ was founded in 2017.
What industry is Genetika+ in?
Genetika+ operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Genetika+ based?
Genetika+ is headquartered in Tel Aviv, Israel.